Study

EORTC-65091-06093

Empirical versus pre-emptive (diagnostic-driven) antifungal therapy of patients treated for haematological malignancies or receiving an allogeneic stem cell transplant. A therapeutic open label phase III strategy study of the EORTC Infectious Diseases and Leukemia Groups

Study documentation Back to result

Trial Status

LT-FU ongoing

Dates

Date of activation: 08-Mar-2012
Date Step1 close: 30-Sep-2015

Data management at EORTC

Yes

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 556 - All Groups: 556

Protocol summary

http://clinicaltrials.gov/study/NCT01288378

NCT number

NCT01288378

EudraCT

2010-020814-27